Novartis AG (NVS)
158.02
-0.84
(-0.53%)
USD |
NYSE |
Aug 24, 16:00
158.00
-0.02
(-0.01%)
Pre-Market: 20:00
Novartis Price : 158.02 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 24, 2026 | 157.12 | 158.46 | 156.77 | 158.02 | 801261.0 |
| Aug 21, 2026 | 156.17 | 159.72 | 156.10 | 158.86 | 1.184M |
| Aug 20, 2026 | 159.07 | 159.33 | 155.87 | 156.24 | 1.526M |
| Aug 19, 2026 | 156.29 | 160.81 | 156.17 | 160.31 | 2.401M |
| Aug 18, 2026 | 153.58 | 155.10 | 153.38 | 154.55 | 1.413M |
| Aug 17, 2026 | 151.23 | 152.62 | 150.83 | 151.97 | 1.199M |
| Aug 14, 2026 | 149.39 | 151.46 | 149.09 | 150.88 | 1.598M |
| Aug 13, 2026 | 152.84 | 153.02 | 151.53 | 151.72 | 1.517M |
| Aug 12, 2026 | 152.03 | 153.43 | 151.82 | 152.32 | 2.471M |
| Aug 11, 2026 | 156.47 | 157.34 | 154.51 | 154.61 | 1.071M |
| Aug 10, 2026 | 155.84 | 156.93 | 155.39 | 156.79 | 995478.0 |
| Aug 07, 2026 | 156.56 | 156.68 | 155.38 | 156.33 | 1.309M |
| Aug 06, 2026 | 155.58 | 155.88 | 153.67 | 154.21 | 1.045M |
| Aug 05, 2026 | 155.23 | 155.56 | 153.81 | 154.44 | 1.178M |
| Aug 04, 2026 | 154.89 | 154.89 | 152.99 | 153.27 | 1.707M |
| Aug 03, 2026 | 155.66 | 156.37 | 153.02 | 153.67 | 1.667M |
| Jul 31, 2026 | 156.99 | 157.12 | 155.03 | 156.15 | 1.546M |
| Jul 30, 2026 | 156.91 | 158.55 | 156.46 | 158.44 | 2.087M |
| Jul 29, 2026 | 159.15 | 159.37 | 157.32 | 158.83 | 1.627M |
| Jul 28, 2026 | 158.07 | 160.34 | 158.02 | 159.85 | 1.690M |
| Jul 27, 2026 | 156.59 | 158.08 | 155.79 | 156.11 | 1.620M |
| Jul 24, 2026 | 156.11 | 156.38 | 154.44 | 155.01 | 1.827M |
| Jul 23, 2026 | 151.71 | 156.94 | 151.44 | 156.14 | 2.105M |
| Jul 22, 2026 | 156.07 | 156.41 | 152.67 | 153.08 | 1.459M |
| Jul 21, 2026 | 155.39 | 159.30 | 153.66 | 153.87 | 2.654M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Roche Holding AG | 57.47 |
| AstraZeneca PLC | 166.71 |
| Johnson & Johnson | 273.04 |
| Eli Lilly & Co. | 1246.93 |
| Merck & Co., Inc. | 150.66 |
Price Related Metrics
| PE Ratio | 23.84 |
| PS Ratio | 5.551 |
| Price to Book Value | 6.963 |
| Price to Free Cash Flow | 20.29 |
| Earnings Yield | 4.19% |
| Market Cap | 289.26B |
| Operating PE Ratio | 18.77 |
| Normalized PE Ratio | 22.21 |